Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
<b>Background:</b> B-cell depletion therapy was demonstrated to be a valid and safe alternative as an adjuvant in oral-pharyngeal pemphigus vulgaris (OPV) patients. We aimed to assess its effects on anti-desmoglein (Dsg) 1 and 3 and leukocytes subsets profile in these patients’ populatio...
Saved in:
Main Authors: | Giulio Fortuna, Elena Calabria, Massimo Aria, Amerigo Giudice, Michele Davide Mignogna |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/25227ff5384d4019a68e59d6e2406d7f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Köbner Phenomenon in a Rituximab-Treated Pemphigus Patient: Beware Disease Activity
by: Soheil Tavakolpour, et al.
Published: (2019) -
IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
by: Salama Hegazy, et al.
Published: (2016) -
A Case Report of Neonatal Pemphigus Vulgaris
by: Marzieh Alipour, et al.
Published: (2021) -
Pemphigus—The Crux of Clinics, Research, and Treatment during the COVID-19 Pandemic
by: Branka Marinović, et al.
Published: (2021) -
Pénfigo vulgar tipo cutáneo: Caso clínico
by: Bello,Cristina, et al.
Published: (2013)